PHGEN I Archive

This is the official Archive of the previous Public Health Genomics European Network Project known as PHGEN I. Content here is given for informational purposes. Please note this project has been successfully accomplished and is now closed. Therefore, content and contacts may be outdated and is not changed for archiving purposes. Below you can find further information on PHGEN I:

What are issues and priorities for Public Health Genomics? What are challenges linked to current national practices in applying genetic testing? Are there examples of best practice in applying genetic testing in Europe? These are questions the EU funded:

“Public Health Genomics European Network (PHGEN I)” set out to answer from  1/2006 - 3/2009).

Aims of PHGEN I

  • To conduct a networking exercise on Public Health Genomics (PHG) covering all EU Member States, Applicant Countries, and EFTA-EEA countries.

  • To identify and list key experts relevant to PHG in these countries.

  • To provide an inventory of PHG-issues and priorities in Europe.

  • To contribute to the co-operation and exchange of information in order to enhance coherence and
    disseminate best practice.

  • To identify legal diversities and barriers in a cross-border market.

  • To promote and stimulate the countries’ efforts in this emerging field by developing PHGEN and by
    supporting effective networking in order to reach sustainability.

Thus, in the long run, PHGEN will serve the European Commission as an ‘early detection unit’ for horizon scanning, fact finding, and monitoring of the integration of genome-based knowledge into public health. 

This project was supported by a grant from the European Commission
Duration period: January, 1st 2006- March, 31st 2009
EU-Project No. 2005313


PHGEN I EU project was run by 

Further Information

Detailed Information on the work of PHGEN I can be found from the following links:

European Health Forum Gastein 2007/2009

Partners and Steering Group

Assessement Phase

Policy Development Phase

Assurance Phase

National Task Force

Working Groups

Resources / Links


+++   NEWS   ++   ACTIVITIES  +++

PHGEN I ended in March 2009. PHGEN II continued at Maastricht University and was led by Prof. Dr. Angela Brand. PHGEN II has officially ended on 30 November 2012 with the reporting period ending on 30 January 2013.


Follow us on TWITTER!


PHGEN II as a Success Story, Biobanks and Personalized Medicine

PHGEN II has been selected as one of the success stories funded by the EU heath programs. The detailed report can be found here. PHGEN II has also been mentioned in the report of the European Commission expert group on biobanks and can be found here. Further our project has been pubished in the European Science Foundation's 'Personalised Medicine for the European Citizen' and can be found here.


Meeting of European Alliance for Personalised Medicine

Commissioner Dalli (speech) and Cyprus Minister Mavroyiannis launched in Brussels on 18 September 2012 the manifesto by the newly-formed European Alliance for Personalised Medicine (EAPM), which brings together patient groups, academia, health professionals and industry, as well as the European Commission and the European Medicines Agency. This news has been covered by APM Health and the European Parliament Magazine. Click here for the picture of our PHGEN coordinator discussing with Commissioner Dalli.


Guidelines Published

During the final meeting in April 2012 in Rome, the PHGEN II European Best Practice Guidelines for Quality Assurance, Provision and Use of Genome-based Information and Technologies have been officially endorsed as the "Declaration of Rome 2012" by the  European Member States as well as European key Institutions and Organizations such as EMA. The "Declaration of Rome 2012" has been published in the Journal "Drug Metabolism and Drug Interactions". It can be downloaded for free at the journal website here. Also a related editorial has also been published in the same journal which can be found at the journal website here. The "Declaration of Rome 2012" is the summary of the European Best Practice Guidelines for Quality Assurance, Provision and Use of Genome-based Information and Technologies produced in the form of 3 individual reports (QA, Provision & Use) by the PHGEN II consortium. These 3 parts can be accees below:

Part I: European Best Practice Guidelines for Quality Assurance of Genome-based Information and Technologies

Part II: European Best Practice Guidelines for Provision of Genome-based Information and Technologies   

Part III: European Best Practice Guidelines for Use of Genome-based Information and Technologies   


PHGEN II Extension Granted

Given the success of the project and realizing the deliverables go beyond the current deliverables, the PHGEN II project has been granted a 6 months cost netural extension by the EAHC. Therefore, the project will continue till the 30 November 2012. Originally the project was till 30 May 2012.


PHGEN II Final Meeting Rome

The PHGEN II final meeting (endorsement panel) took place in Rome, Italy. It was a success. Further information can be found here.

PHGEN Definitions

PHGEN II has released the definitions list which will be used as the guiding tools for the development of the guidelines. These constitute definitions developed during PHGEN I as well as new definitions. This can be found by clicking the link here.


The 3rd and final Steering Committee Meeting of PHGEN II took place on 23 February 2012 in Maastricht, The Netherlands. Further information can be found here.


ITFoM is one of six pilot projects in the European Future and Emerging Technologies Flagship scheme. These projects are vying for €1 billion funding from both the European Commission, Member States and other sources over ten years in order to generate a scientific revolution. Further information can be found from here.


Old information and news of PHGEN II can be found in the Archives here.



Public Health Genomics Journal
(Journal published in collaboration with GRaPH-Int)

'Public Health Genomics' is the first peer-reviewed international journal to focus on the translation of genome-based knowledge and technologies into public policy, disease prevention and the improvement of population health. It is a multidisciplinary bi-monthly forum containing conceptual and original research articles, editorials, reviews, short communications, country reports, case studies, viewpoints, news and various other features about the nature of public health genomics and related concepts.

For more details please visit

PHGEN II is currently also developing a Wiki. This can be accessed here

PHGEN II is coordinated by the Institute for Public Health Genomics (IPHG) at Maastricht University.  The publication list contributed by partners of PHGEN II can be found here.

The IPHG coordinated the bachelor's program Public Health Genomics. The output of the successful course was a report made by the students with supervision from their supervisors. The report can be found here.

Up coming Events

PHGEN II events have now officially ended.